$ECAT

Saba Capital Management, L.P. sold $1.7M of ECAT (indirect holdings)

Saba Capital Management, L.P. sold 111,871 indirectly-held shares of BlackRock ESG Capital Allocation Term Trust (ECAT) at an average of $15.52 ($15.41–$15.56, $1.74M total) across 2 trades over 2026-08-25 to 2026-08-26.

Original reporting
SEC EDGAR · Saba Capital Management, L.P.
Published Aug 27, 2026, 3:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 3:54 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ECAT
Neutral
high confidence
Mentioned
$ECAT
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ECATNeutralLow
01

Why it matters

The transaction is a routine insider sale with limited market impact.

02

Market read

Low relevance; routine insider transaction with minimal price effect.

03

What to watch

Potential upcoming regulatory changes to ESG funds could influence future holdings.

Relevance 6/10Novelty 2/10Timing: filed Aug 27

Background

Form 4 filing by Saba Capital Management discloses an indirect sale of ECAT shares.

Company-level read

Ticker impact

$ECATNeutralHigh confidence
Context

SEC Form 4 shows Saba Capital sold ~1.7M USD of ECAT shares, reducing its stake.

Expected impact

little to no immediate price effect

Evidence & confidence

Sale represents ~0.8% of total shares; typical 10b5-1 plan execution without market impact.

Market effects

none

none

none

Counterpoint

Sale could be a routine portfolio rebalancing, not a bearish signal.

Key entities

  • Saba Capital Management, L.P.

    Reporter of the insider transaction.

  • BlackRock ESG Capital Allocation Term Trust

    The trust whose shares were sold.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles